Ad
related to: mnkd share price history 4 years latersuperstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
History [ edit ] Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology.
Net loss applicable to common stockholders for fiscal year 2012 was $(169.4) million, or $(0.94) per share based on 180.9 million weighted average shares outstanding, compared to net loss ...
MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the company announced the FDA issued a complete response to United Therapeutics regarding the New Drug Application ...
The EBU net revenue for the quarter was $20 million or 10% versus last year, and we saw Afrezza overall for the year slightly impacted by headwinds throughout the first three quarters as we focus ...
After three quarters of positive earnings per share from Q3, 2023 through the first quarter of 2024 we had a net loss in the current quarter of $2 million, or $0.01 per share.
For premium support please call: 800-290-4726 more ways to reach us
MannKind (MNKD) delivered earnings and revenue surprises of -25.00% and 31.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Four Years Later, originally titled Four Years is an eight-part Australian-Indian romance drama, premiering on SBS and SBS on Demand on 2 October 2024. It is created, co-written, and executive produced by Mithila Gupta, and stars Shahana Goswami , Akshay Ajit Singh, Kate Box , and Luke Arnold .
Ad
related to: mnkd share price history 4 years latersuperstockscreener.com has been visited by 10K+ users in the past month